The global naltrexone and buprenorphine market size was valued at USD 4.2 billion in 2024 and is projected to grow from USD 5.5 billion in 2026 to USD 9.8 billion by 2033, at a CAGR of 9.3% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 39.4% in ... Read More »
July 2025The global diabetic ketoacidosis treatment market size was estimated at USD 874.51 million in 2024 and is projected to reach USD 1,272.36 million by 2033, growing at a CAGR of 4.26% from 2025 to 2033. This strong growth trajectory is propelled by the escalating global prevalence of diabe... Read More »
July 2025The U.S. Tremfya market size was estimated at USD 3.00 billion in 2024 and is projected to reach USD 4.89 billion by 2033, growing at a CAGR of 5.32% from 2025 to 2033. The rising incidence of chronic plaque psoriasis and psoriatic arthritis in the U.S. is contributing to increased deman... Read More »
July 2025The U.S. allergy diagnostics & therapeutics market size was valued at USD 10.86 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2030. The market is driven by the increasing prevalence of allergies among the population, and environmental factors such as increas... Read More »
June 2025The global infant nutrition market size was valued at USD 392.1 million in 2024 and is projected to grow from USD 452.5 million in 2026 to USD 611.1 million by 2030, at a CAGR of 7.7% from 2025 to 2030. Asia Pacific dominated the market, accounting for a revenue share of 24.2% in 2024.... Read More »
June 2025The U.S. androgenetic alopecia market was valued at USD 979.1 million in 2024 and is expected to grow at a CAGR of 6.6% from 2025 to 2030. The increasing incidence of Androgenic Alopecia (AGA) is driving market growth. Androgenetic alopecia, the most common form of hair loss, affects a s... Read More »
June 2025The global tremfya market size was estimated at USD 3.67 billion in 2024 and is projected to reach USD 7.29 billion by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greater demand for advanced biol... Read More »
June 2025The global herbal supplements market size was valued at USD 42.3 billion in 2024 and is projected to grow from USD 49.3 billion in 2026 to USD 90.2 billion by 2033, at a CAGR of 8.9% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 26.3% in 2024. T... Read More »
June 2025The global rozanolixizumab (Rystiggo) market size was estimated at USD 218.61 million in 2024 and is projected to reach USD 1,700.40 million by 2033, growing at a CAGR of 15.22% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greate... Read More »
June 2025The U.S. anti-aging supplements market was valued at USD 1.39 billion in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2030. Growth is driven by increasing health consciousness, rising life expectancy, and a proactive approach to age-related health management among U.S. con... Read More »
June 2025The U.S. keytruda market size was estimated at USD 17.87 billion in 2024 and is projected to decline at a CAGR of -3.12% from 2025 to 2033. The market faces challenges from the impending patent expiration in 2028, introducing biosimilar competition. Although the decline is expected, mark... Read More »
June 2025The U.S. Rozanolixizumab (Rystiggo) market size was estimated at USD 199.13 million in 2024 and is expected to grow at a CAGR of 7.30% from 2025 to 2033. The U.S. Rozanolixizumab (Rystiggo) market focuses on treating generalized myasthenia gravis (gMG) in adults with anti-AChR or anti-Mu... Read More »
June 2025The global liver disease therapeutics market size was valued at USD 20.3 billion in 2024 and is projected to grow from USD 23.6 billion in 2026 to USD 40.3 billion by 2033, at a CAGR of 7.9% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 39.9% in... Read More »
June 2025The Germany pharmaceutical market size was estimated at USD 95.11 billion in 2024 and is expected to grow at a CAGR of 5.31% from 2025 to 2033. The growth is driven by advances in digital health technologies supporting drug development and personalized medicine, such as AI and genome seq... Read More »
June 2025The global onychomycosis market was estimated at USD 3.81 billion in 2024 and is projected to reach USD 5.74 billion by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The market is driven by the rising prevalence of fungal nail infections, increasing incidence of chronic conditions s... Read More »
June 2025The global peanut allergy treatment market size was valued at USD 536.8 million in 2024 and is projected to grow from USD 643.1 million in 2026 to USD 1,461.5 million by 2033, at a CAGR of 11.4% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 37.3... Read More »
June 2025The U.S. ultomiris drug market size was estimated at USD 1.46 billion in 2024 and is projected to reach USD 8.14 billion by 2033, growing at a CAGR of 19.93% from 2025 to 2033. Ultomiris continues to gain traction due to its extended dosing interval, which improves patient compliance and... Read More »
June 2025The UK Alzheimer’s therapeutics market size was estimated at USD 263.66 million in 2024 and is projected to reach USD 498.80 million by 2033, growing at a CAGR of 7.84% from 2025 to 2033. The increasing prevalence of Alzheimer’s disease in the UK is driving demand for effecti... Read More »
June 2025The U.S. Zilbrysq (Zilucoplan) market size was estimated at USD 60.61 million in 2024 and is projected to grow at a CAGR of 21.64% from 2025 to 2030. The U.S. Zilbrysq (Zilucoplan) industry is witnessing robust growth following its FDA approval in October 2023 for the treatment of anti-A... Read More »
June 2025The global zilbrysq (zilucoplan) market size was estimated at USD 77.92 million in 2024 and is projected to reach USD 679.58 million by 2030, growing at a CAGR of 28.39% from 2025 to 2030. The market is experiencing significant growth, driven by its regulatory approvals in key markets su... Read More »
June 2025